Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Duke University Health System, Durham, NC.
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Duke University Health System, Durham, NC.
Chest. 2014 Mar 1;145(3):604-611. doi: 10.1378/chest.12-2127.
Neurobehavioral functioning is widely recognized as being an important consideration in lung transplant candidates, but little is known about whether these factors are related to clinical outcomes. The present study examined the relationship of neurobehavioral functioning, including measures of executive function and memory, depression, and anxiety, to long-term survival among lung transplant recipients.
The sample was drawn from 201 patients who underwent transplantation at Duke University and Washington University who participated in a dual-site clinical trial investigating medical and psychosocial outcomes in transplant candidates with end-stage lung disease. All patients completed the Beck Depression Inventory-II (BDI-II) and Spielberger State-Trait Anxiety Inventory at baseline and again after 12 weeks, while a subset of 86 patients from Duke University also completed neurocognitive testing. Patients were followed for survival up to 12 years after completing baseline assessments.
One hundred eleven patients died over a mean follow-up of 10.8 years (SD=0.8). Baseline depression, anxiety, and neurocognitive function were examined as predictors of posttransplant survival, controlling for age, 6-min walk distance, FEV, and native disease; education and cardiovascular risk factors were also included in the model for neurocognition. Lower executive function (hazard ratio [HR]=1.09, P=.012) and memory performance (HR=1.11, P=.030) were independently associated with greater mortality following lung transplant. Although pretransplant depression and anxiety were not predictive of mortality, patients who scored>13 on the BDI-II at baseline and after 3 months pretransplant had greater mortality (HR=1.85 [95% CI, 1.04, 3.28], P=.036).
Neurobehavioral functioning, including persistently elevated depressive symptoms and lower neurocognitive performance, was associated with reduced survival after lung transplantation.
ClinicalTrials.gov; No.: NCT00113139; URL: www.clinicaltrials.gov.
神经行为功能被广泛认为是肺移植候选人的一个重要考虑因素,但人们对这些因素是否与临床结果有关知之甚少。本研究考察了神经行为功能(包括执行功能和记忆、抑郁和焦虑的测量)与肺移植受者长期生存的关系。
该样本来自在杜克大学和华盛顿大学接受移植的 201 名患者,他们参加了一项双站点临床试验,该试验调查了终末期肺病移植候选者的医疗和社会心理结果。所有患者在基线时和 12 周后完成贝克抑郁量表第二版(BDI-II)和斯皮尔伯格状态-特质焦虑量表,而来自杜克大学的 86 名患者子集还完成了神经认知测试。患者在完成基线评估后进行了长达 12 年的生存随访。
在平均 10.8 年(SD=0.8)的随访中,有 111 名患者死亡。在控制年龄、6 分钟步行距离、FEV 和原发病;教育和心血管危险因素也包括在神经认知模型中后,将基线抑郁、焦虑和神经认知功能作为移植后生存的预测因子进行了检查。较低的执行功能(危险比[HR]=1.09,P=.012)和记忆表现(HR=1.11,P=.030)与肺移植后更高的死亡率独立相关。尽管移植前的抑郁和焦虑与死亡率无关,但在移植前 3 个月 BDI-II 基线和随访时得分>13 的患者死亡率更高(HR=1.85[95%CI,1.04, 3.28],P=.036)。
神经行为功能,包括持续升高的抑郁症状和较低的神经认知表现,与肺移植后生存减少相关。
ClinicalTrials.gov;编号:NCT00113139;网址:www.clinicaltrials.gov。